cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
DC297618 | .e | 12 to 456 | 1 to 445 | 445/445 (100 %) | 0 diff (100 %id) | ||||
Z24892 | leg muscle, skeletal muscle | .h | 816 to 1031 | 216 to 1 | 216/216 (100 %) | 1 diff (99.6 %id) | |||
Z28625 | leg muscle, skeletal muscle | .h | 410 to 666 | 1 to 257 | 257/257 (100 %) | 1 diff (99.7 %id) | |||
AA781994 | .f-u | 738 to 1172 | 436 to 1 | 436/436 (100 %) | 1 diff (99.8 %id) | ||||
T11850 | .h | 764 to 902 | 140 to 1 | 388/420 (92 %) | 21 diff (95.0 %id) | ||||
AA091470 | .h | 1 to 276 | 1 to 272 | tiling clone, | 272/306 (88 %) | 11 diff (96.5 %id) | |||
AA302984 | brain | .a | 1092 to 1392 | 1 to 302 | 302/302 (100 %) | 1 diff (99.7 %id) | |||
AA303758 | aorta | .h | 536 to 804 | 1 to 270 | 270/270 (100 %) | 2 diff (99.3 %id) | |||
AA345976 | gall bladder | .h | 263 to 478 | 95 to 312 | 218/312 (69 %) | 6 diff (98.1 %id) | |||
AA350538 | brain | .a | 1076 to 1474 | 1 to 400 | 400/400 (100 %) | 2 diff (99.5 %id) | |||
AA351438 | brain | .h | 899 to 1140 | 242 to 1 | 242/242 (100 %) | 1 diff (99.6 %id) | |||
AA361061 | .c | 958 to 1231 | 1 to 274 | 274/275 (99 %) | 2 diff (99.3 %id) | ||||
BP193978 | brain | .a | 135 to 716 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | |||
AV706010 | adrenal gland | .g | 1 to 637 | 1 to 637 | G68X W102L S108F G112R | tiling clone, | 637/637 (100 %) | 9 diff (98.6 %id) | |
BP381176 | adipose tissue | .a | 43 to 669 | 1 to 627 | 627/627 (100 %) | 1 diff (99.9 %id) | |||
DA013372 | adrenal gland | .a | 55 to 607 | 2 to 554 | capped | 553/553 (100 %) | 3 diff (99.5 %id) | ||
AI904297 | breast | .i | 321 to 423 | 1 to 104 | 104/104 (100 %) | 6 diff (94.3 %id) | |||
AK002026 | placenta | .a | 23 to 2521 | 1 to 2499 | exact | available from FLJ, | 2499/2499 (100 %) | 1 diff (100.0 %id) | |
AK022105 | whole embryo, mainly body | .a | 54 to 2520 | 1 to 2467 | R186G Y272C | available from FLJ, | 2467/2467 (100 %) | 2 diff (100.0 %id) | |
AK024628 | adipose tissue | .a | 1014 to 2520 | 1 to 1507 | available from FLJ, AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 1507/1507 (100 %) | 0 diff (100 %id) | |
AK222472 | adipose tissue | .a | 43 to 1426 | 1 to 1384 | Q213R | 1384/1384 (100 %) | 1 diff (100.0 %id) | ||
AK293814 | cerebellum | .d | 1 to 1044 | 1 to 1044 | A119T L126S | tiling clone, | 1044/1044 (100 %) | 3 diff (99.8 %id) | |
AK297655 | brain | .c | 1 to 892 | 1 to 892 | exact | tiling clone, | 892/892 (100 %) | 0 diff (100 %id) | |
DA029673 | .a | 55 to 626 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | |||
AW175666 | breast | .i | 336 to 620 | 20 to 305 | tiling clone, | 286/310 (92 %) | 7 diff (97.8 %id) | ||
AW175754 | breast | .h | 299 to 454 | 180 to 25 | 156/181 (86 %) | 0 diff (100 %id) | |||
AW364620 | denis_drash | .h | 167 to 580 | 8 to 420 | 413/420 (98 %) | 6 diff (98.6 %id) | |||
AW364627 | denis_drash | .h | 277 to 680 | 419 to 17 | 403/419 (96 %) | 0 diff (100 %id) | |||
AW364644 | denis_drash | .h | 189 to 680 | 497 to 8 | 490/499 (98 %) | 0 diff (100 %id) | |||
AW384799 | head_neck | .h | 167 to 636 | 475 to 9 | 467/486 (96 %) | 0 diff (100 %id) | |||
AW384803 | head_neck | .h | 167 to 629 | 468 to 7 | 462/479 (96 %) | 0 diff (100 %id) | |||
AW384806 | head_neck | .h | 168 to 682 | 1 to 514 | 514/515 (99 %) | 12 diff (97.7 %id) | |||
AW384819 | head_neck | .h | 170 to 682 | 1 to 512 | 512/513 (99 %) | 9 diff (98.3 %id) | |||
AW384821 | head_neck | .h | 170 to 682 | 16 to 527 | 512/528 (96 %) | 9 diff (98.3 %id) | |||
AW385087 | head_neck | .c | 893 to 1101 | 1 to 209 | 209/242 (86 %) | 1 diff (99.6 %id) | |||
AW393459 | stomach | .h | 167 to 674 | 511 to 4 | 508/523 (97 %) | 0 diff (100 %id) | |||
AW610187 | stomach | .h | 175 to 664 | 490 to 1 | 490/490 (100 %) | 1 diff (99.8 %id) | |||
AW803245 | uterus | .h | 914 to 1126 | 1 to 213 | 213/222 (95 %) | 3 diff (98.7 %id) | |||
AW953347 | .a | 1074 to 1364 | 12 to 302 | 291/302 (96 %) | 12 diff (96.1 %id) | ||||
AW959026 | .c | 959 to 1515 | 1 to 558 | 558/558 (100 %) | 12 diff (97.9 %id) | ||||
AW970649 | .f-u | 935 to 1344 | 412 to 1 | tiling clone, | Submitted on the opposite strand | 412/532 (77 %) | 10 diff (98.2 %id) | ||
BC050538 | Blood, adult leukocytes | .a | 63 to 2520 | 1 to 2458 | A119T L126S | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 2458/2458 (100 %) | 2 diff (100.0 %id) |
BE774164 | uterus | .h | 888 to 1006 | 120 to 2 | 119/120 (99 %) | 0 diff (100 %id) | |||
BF763100 | colon_est | .f-u | 459 to 798 | 27 to 365 | 339/365 (92 %) | 6 diff (98.4 %id) | |||
BF763248 | colon_est | .f-u | 468 to 709 | 246 to 5 | Submitted on the opposite strand | 242/246 (98 %) | 0 diff (100 %id) | ||
BF763249 | colon_est | .f-u | 468 to 822 | 1 to 355 | 355/355 (100 %) | 2 diff (99.5 %id) | |||
BF805228 | colon_ins | .a | 1049 to 1497 | 449 to 1 | Submitted on the opposite strand | 449/449 (100 %) | 0 diff (100 %id) | ||
BF805231 | colon_ins | .a | 1049 to 1497 | 449 to 1 | Submitted on the opposite strand | 449/449 (100 %) | 0 diff (100 %id) | ||
BF935767 | nervous_tumor | .a | 1084 to 1339 | 267 to 12 | Submitted on the opposite strand | 256/267 (95 %) | 16 diff (94.1 %id) | ||
BI003209 | head_normal | .a | 697 to 928 | 229 to 3 | 227/229 (99 %) | 0 diff (100 %id) | |||
DA047776 | .a | 387 to 915 | 2 to 530 | capped | 529/529 (100 %) | 2 diff (99.7 %id) | |||
BQ301984 | breast | .a | 323 to 623 | 15 to 314 | 300/326 (92 %) | 10 diff (97.0 %id) | |||
BQ301987 | breast | .a | 323 to 623 | 14 to 314 | 301/326 (92 %) | 9 diff (97.3 %id) | |||
DA055449 | cerebellum | .a | 55 to 439 | 2 to 386 | capped | 385/385 (100 %) | 1 diff (99.8 %id) | ||
DA062918 | cerebellum | .a | 92 to 646 | 2 to 556 | capped | 555/555 (100 %) | 2 diff (99.7 %id) | ||
DA073654 | cerebellum | .b | 3 to 491 | 2 to 490 | capped | 489/489 (100 %) | 0 diff (100 %id) | ||
DA087985 | cerebellum | .a | 55 to 505 | 2 to 452 | capped | 451/451 (100 %) | 0 diff (100 %id) | ||
DC307558 | cerebellum | .d | 1 to 588 | 1 to 588 | 588/588 (100 %) | 3 diff (99.5 %id) | |||
DA158220 | amygdala | .b | 46 to 556 | 2 to 512 | tiling clone, capped | 511/511 (100 %) | 0 diff (100 %id) | ||
DA180715 | amygdala | .l-u | 1 to 560 | 2 to 561 | exact | capped | 560/560 (100 %) | 1 diff (99.9 %id) | |
DA182109 | amygdala | .a | 55 to 519 | 2 to 469 | capped | 468/468 (100 %) | 4 diff (99.2 %id) | ||
DA240618 | brain | .a | 55 to 642 | 2 to 589 | capped | 588/588 (100 %) | 1 diff (99.9 %id) | ||
DA251826 | caudate nucleus | .a | 55 to 629 | 2 to 576 | capped | 575/575 (100 %) | 2 diff (99.7 %id) | ||
DA289885 | hippocampus | .a | 55 to 624 | 2 to 571 | capped | 570/570 (100 %) | 4 diff (99.3 %id) | ||
DA304267 | hippocampus | .a | 55 to 625 | 2 to 572 | capped | 571/571 (100 %) | 1 diff (99.9 %id) | ||
DA346478 | substantia nigra | .a | 204 to 758 | 2 to 557 | capped | 556/556 (100 %) | 6 diff (99.0 %id) | ||
DA383711 | thalamus | .a | 55 to 687 | 2 to 634 | capped | 633/634 (99 %) | 2 diff (99.7 %id) | ||
DA394432 | thalamus | .a | 55 to 644 | 2 to 591 | capped | 590/590 (100 %) | 0 diff (100 %id) | ||
DA396454 | thalamus | .a | 50 to 632 | 2 to 584 | capped | 583/583 (100 %) | 6 diff (99.0 %id) | ||
DA403606 | thalamus | .j | 1 to 549 | 2 to 552 | tiling clone, capped | 551/551 (100 %) | 4 diff (99.3 %id) | ||
BX104649 | liver and spleen | .h | 542 to 1131 | 1 to 590 | 590/590 (100 %) | 1 diff (99.9 %id) | |||
C05096 | heart | .h | 375 to 740 | 11 to 376 | 366/376 (97 %) | 6 diff (98.5 %id) | |||
CB266274 | adipose | .a | 751 to 1222 | 1 to 472 | 472/472 (100 %) | 2 diff (99.6 %id) | |||
CB267757 | adipose | .l-u | 105 to 528 | 1 to 423 | R18W A19H Q20R G21A S22L ... | tiling clone, | 423/423 (100 %) | 2 diff (99.6 %id) | |
CD629218 | .a | 861 to 1385 | 1 to 527 | 527/538 (97 %) | 8 diff (98.6 %id) | ||||
AU279733 | .a | 54 to 612 | 1 to 560 | 560/560 (100 %) | 1 diff (99.9 %id) | ||||
CR621437 | Placenta Cot 25-normalized | .a | 60 to 2467 | 1 to 2408 | exact | 2408/2408 (100 %) | 0 diff (100 %id) | ||
CR745055 | lymph node, lymphoma, follicular mixed small and largecell | .h | 700 to 1139 | 454 to 15 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 440/440 (100 %) | 0 diff (100 %id) | |
AL521331 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 1602 to 2505 | 900 to 1 | 900/900 (100 %) | 7 diff (99.3 %id) | |||
AL521332 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 270 to 1130 | 1 to 860 | 860/860 (100 %) | 4 diff (99.6 %id) | |||
BX392058 | Neuroblastoma Cot 10-normalized | .h | 658 to 1137 | 496 to 14 | 483/789 (61 %) | 0 diff (100 %id) | |||
AL522133 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 1733 to 2370 | 773 to 136 | 638/830 (76 %) | 0 diff (100 %id) | |||
AL522134 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 396 to 1228 | 1 to 831 | 831/831 (100 %) | 2 diff (99.8 %id) | |||
AL523445 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 6 to 916 | 4 to 912 | 909/912 (99 %) | 19 diff (98.0 %id) | |||
AL562207 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .h | 1 to 1107 | 1107 to -6 | tiling clone, | 1107/1174 (94 %) | 22 diff (98.2 %id) | ||
BX403125 | Neuroblastoma Cot 25-normalized | .h | 189 to 1125 | 937 to 1 | 937/937 (100 %) | 16 diff (98.3 %id) | |||
BX403126 | Neuroblastoma Cot 25-normalized | .a | 6 to 885 | 4 to 881 | 878/881 (99 %) | 13 diff (98.6 %id) | |||
AL523419 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 1452 to 2465 | 1005 to 1 | 1005/1067 (94 %) | 21 diff (98.1 %id) | |||
AL523420 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 51 to 1046 | 1 to 990 | 990/1044 (94 %) | 11 diff (99.0 %id) | |||
AL525496 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 1 to 906 | 1 to 892 | 892/902 (98 %) | 21 diff (97.7 %id) | |||
AL562512 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 1403 to 2493 | 1076 to 1 | 1076/1129 (95 %) | 18 diff (98.5 %id) | |||
BX332972 | Neuroblastoma Cot 25-normalized | .h | 19 to 1124 | 1099 to 1 | 1099/1119 (98 %) | 19 diff (98.4 %id) | |||
BX372885 | Neuroblastoma Cot 25-normalized | .h | 619 to 1123 | 518 to 1 | 518/531 (97 %) | 42 diff (92.1 %id) | |||
AL529919 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .a | 1477 to 2464 | 983 to 1 | 983/1036 (94 %) | 18 diff (98.3 %id) | |||
AL529920 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .a | 2 to 1041 | 1 to 1032 | tiling clone, | 1032/1113 (92 %) | 15 diff (98.7 %id) | ||
BX416976 | placenta | .a | 88 to 982 | 1 to 892 | 892/892 (100 %) | 4 diff (99.6 %id) | |||
BX454248 | placenta | .a | 1650 to 2501 | 871 to 12 | 860/893 (96 %) | 87 diff (90.3 %id) | |||
AL557167 | T cells (Jurkat cell line), T cells from T cell leukemia | .a | 56 to 978 | 1 to 920 | 920/925 (99 %) | 9 diff (99.1 %id) | |||
AL579257 | T cells (Jurkat cell line), T cells from T cell leukemia | .a | 1467 to 2478 | 1004 to 1 | 1004/1132 (88 %) | 32 diff (97.2 %id) | |||
BX462548 | T cells (Jurkat cell line) | .a | 40 to 972 | 1 to 928 | 928/939 (98 %) | 15 diff (98.5 %id) | |||
AL552350 | placenta, Placenta Cot 25-normalized | .a | 68 to 961 | 8 to 899 | 892/899 (99 %) | 10 diff (98.9 %id) | |||
AL575668 | placenta, Placenta Cot 25-normalized | .h | 155 to 1085 | 933 to 1 | 933/933 (100 %) | 9 diff (99.1 %id) | |||
BX327311 | Placenta Cot 25-normalized | .a | 841 to 1558 | 1 to 724 | 724/921 (78 %) | 41 diff (95.6 %id) | |||
BX327312 | Placenta Cot 25-normalized | .a | 838 to 1131 | 1 to 293 | 293/343 (85 %) | 9 diff (97.4 %id) | |||
BX371871 | Placenta Cot 25-normalized | .a | 741 to 1647 | 955 to 56 | 900/955 (94 %) | 14 diff (98.6 %id) | |||
BX349362 | .h | 1005 to 1138 | 1 to 133 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 133/133 (100 %) | 2 diff (98.5 %id) | ||
BX385568 | .h | 506 to 1138 | 1 to 634 | 634/634 (100 %) | 3 diff (99.6 %id) | ||||
BX504234 | .h | 558 to 1012 | 1 to 457 | 457/457 (100 %) | 2 diff (99.6 %id) | ||||
DT217366 | brain | .a | 54 to 677 | 1 to 624 | 624/624 (100 %) | 2 diff (99.7 %id) | |||
EL951751 | eyeball | .c | 942 to 1510 | 1 to 570 | 570/570 (100 %) | 4 diff (99.3 %id) | |||
DA484088 | brain | .a | 55 to 605 | 2 to 557 | capped | 556/556 (100 %) | 5 diff (99.2 %id) | ||
DA484293 | brain | .a | 55 to 548 | 2 to 495 | capped | 494/494 (100 %) | 3 diff (99.4 %id) | ||
DA491087 | brain | .a | 51 to 614 | 2 to 565 | capped | 564/564 (100 %) | 2 diff (99.7 %id) | ||
DA494863 | brain | .a | 55 to 615 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DC351695 | brain | .e | 8 to 555 | 1 to 550 | tiling clone, | 550/550 (100 %) | 12 diff (97.9 %id) | ||
DA507241 | brain | .a | 23 to 548 | 2 to 527 | capped | 526/526 (100 %) | 0 diff (100 %id) | ||
DC353234 | brain | .e | 8 to 501 | 1 to 494 | 494/494 (100 %) | 2 diff (99.6 %id) | |||
DA526099 | brain | .a | 23 to 552 | 2 to 531 | capped | 530/536 (98 %) | 3 diff (99.5 %id) | ||
DA531567 | brain | .a | 55 to 658 | 2 to 612 | capped | 611/611 (100 %) | 10 diff (98.4 %id) | ||
DC354161 | brain | .c | 1 to 568 | 1 to 569 | 569/569 (100 %) | 1 diff (99.9 %id) | |||
CD672606 | eye, Iris | .h | 431 to 837 | 1 to 407 | 407/407 (100 %) | 10 diff (97.6 %id) | |||
AV653956 | corresponding non cancerous liver tissue | .a | 962 to 1356 | 1 to 395 | Submitted on the opposite strand | 395/395 (100 %) | 0 diff (100 %id) | ||
DB474996 | hippocampus | .a | 54 to 552 | 1 to 499 | 499/500 (99 %) | 6 diff (98.8 %id) | |||
DB495381 | hypothalamus | .a | 54 to 552 | 1 to 499 | 499/502 (99 %) | 4 diff (99.3 %id) | |||
DB566435 | hypothalamus | .h | 690 to 1138 | 1 to 449 | Submitted on the opposite strand | 449/449 (100 %) | 19 diff (95.8 %id) | ||
DB506378 | hypothalamus | .a | 54 to 537 | 1 to 484 | 484/484 (100 %) | 3 diff (99.4 %id) | |||
DB577679 | hypothalamus | .h | 651 to 1140 | 1 to 490 | Submitted on the opposite strand | 490/490 (100 %) | 5 diff (99.0 %id) | ||
BP234701 | coronary artery | .a | 659 to 1240 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
DA562597 | heart | .a | 55 to 558 | 2 to 506 | capped | 505/505 (100 %) | 2 diff (99.7 %id) | ||
AU121043 | whole embryo, mainly body | .a | 55 to 837 | 2 to 805 | capped | 804/805 (99 %) | 32 diff (96.1 %id) | ||
AU146948 | whole embryo, mainly body | .a | 1947 to 2520 | 577 to 1 | 577/579 (99 %) | 15 diff (97.5 %id) | |||
DA578566 | .a | 55 to 612 | 2 to 559 | capped | 558/558 (100 %) | 2 diff (99.7 %id) | |||
BJ990246 | hepatoblastoma | .l-u | 1 to 584 | 17 to 600 | exact | tiling clone, | 589/600 (98 %) | 6 diff (99.0 %id) | |
DA593992 | lung | .a | 54 to 334 | 2 to 282 | capped | 281/281 (100 %) | 1 diff (99.7 %id) | ||
R43856 | whole brain | .h | 836 to 1140 | 318 to 9 | 310/323 (95 %) | 0 diff (100 %id) | |||
T98220 | lung | .h | 55 to 377 | 1 to 336 | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 336/347 (96 %) | 15 diff (95.7 %id) | ||
T98221 | lung | .h | 846 to 1138 | 304 to 12 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 293/295 (99 %) | 1 diff (99.7 %id) | |
R73189 | breast | .f-u | 615 to 1002 | 1 to 394 | 394/460 (85 %) | 10 diff (97.9 %id) | |||
N57131 | placenta | .a | 1187 to 1607 | 1 to 426 | 426/428 (99 %) | 13 diff (97.0 %id) | |||
N51551 | multiple sclerosis lesions | .h | 677 to 1138 | 465 to 1 | 465/465 (100 %) | 7 diff (98.5 %id) | |||
N69289 | liver and spleen | .h | 876 to 1138 | 277 to 13 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 265/265 (100 %) | 1 diff (99.7 %id) | |
N94109 | liver and spleen | .h | 543 to 906 | 1 to 368 | fully sequenced, | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 368/368 (100 %) | 4 diff (99.0 %id) | |
N94998 | parathyroid gland, parathyroid tumor | .h | 619 to 1138 | 537 to 18 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 520/611 (85 %) | 16 diff (97.4 %id) | |
N91247 | parathyroid gland, parathyroid tumor | .h | 914 to 1142 | 233 to 1 | fully sequenced, | 233/233 (100 %) | 4 diff (98.3 %id) | ||
W19900 | parathyroid gland, parathyroid tumor | .h | 560 to 944 | 1 to 388 | fully sequenced, | 388/388 (100 %) | 5 diff (98.8 %id) | ||
W74004 | heart | .h | 525 to 971 | 1 to 447 | 447/447 (100 %) | 3 diff (99.4 %id) | |||
AA055526 | heart | .h | 436 to 797 | 1 to 365 | fully sequenced, | 365/365 (100 %) | 5 diff (98.7 %id) | ||
AA055527 | heart | .h | 767 to 1141 | 377 to 1 | fully sequenced, | 377/377 (100 %) | 2 diff (99.5 %id) | ||
AA732928 | heart | .h | 690 to 1140 | 450 to 1 | 450/450 (100 %) | 3 diff (99.4 %id) | |||
AA171610 | .h | 740 to 1135 | 396 to 1 | fully sequenced, | 396/396 (100 %) | 5 diff (98.8 %id) | |||
AA171769 | .h | 442 to 770 | 1 to 329 | fully sequenced, | 329/329 (100 %) | 1 diff (99.7 %id) | |||
AA437121 | .f-u | 919 to 1349 | 430 to 2 | tiling clone, | 429/430 (99 %) | 0 diff (100 %id) | |||
AA522434 | colon | .f-u | 975 to 1342 | 370 to 1 | 370/370 (100 %) | 4 diff (99.0 %id) | |||
AA533115 | normal prostatic epithelial cells, Prostate | .h | 628 to 1083 | 10 to 459 | 450/507 (88 %) | 28 diff (94.5 %id) | |||
AA633460 | breast | .h | 766 to 1138 | 374 to 2 | 373/374 (99 %) | 0 diff (100 %id) | |||
AA622778 | breast | .h | 780 to 1138 | 359 to 1 | 359/359 (100 %) | 1 diff (99.8 %id) | |||
AA767850 | germinal center B cell | .h | 713 to 1138 | 439 to 14 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 426/426 (100 %) | 3 diff (99.3 %id) | |
AA806672 | germinal center B cell | .h | 961 to 1138 | 191 to 14 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 178/178 (100 %) | 2 diff (98.9 %id) | |
AA854252 | parathyroid gland, parathyroid tumor | .h | 719 to 1139 | 427 to 8 | 420/427 (98 %) | 0 diff (100 %id) | |||
AA890387 | parathyroid gland, parathyroid tumor | .h | 952 to 1139 | 195 to 8 | 188/195 (96 %) | 0 diff (100 %id) | |||
AA953527 | pooled | .h | 855 to 1140 | 286 to 1 | 286/286 (100 %) | 1 diff (99.7 %id) | |||
AA969705 | Kidney, kidney tumor | .f-u | 925 to 1170 | 246 to 1 | 246/246 (100 %) | 0 diff (100 %id) | |||
AA995597 | 2 pooled tumors (clear cell type), Kidney | .h | 769 to 1139 | 397 to 27 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 371/371 (100 %) | 1 diff (99.8 %id) | |
AI023447 | liver and spleen | .h | 864 to 1138 | 292 to 18 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 275/275 (100 %) | 15 diff (94.6 %id) | |
AI042002 | parathyroid gland, parathyroid tumor | .h | 553 to 1139 | 594 to 8 | 587/594 (98 %) | 0 diff (100 %id) | |||
AI079130 | parathyroid gland, parathyroid tumor | .h | 898 to 1139 | 248 to 7 | 242/248 (97 %) | 0 diff (100 %id) | |||
AI079546 | liver and spleen | .h | 568 to 1138 | 571 to 1 | 571/571 (100 %) | 1 diff (99.9 %id) | |||
AI094138 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .h | 591 to 1138 | 553 to 6 | 548/553 (99 %) | 0 diff (100 %id) | |||
AI185347 | lung | .h | 723 to 1138 | 427 to 13 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 415/415 (100 %) | 5 diff (98.8 %id) | |
AI193764 | lung | .h | 882 to 1140 | 269 to 11 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 259/259 (100 %) | 1 diff (99.7 %id) | |
AI200193 | lung | .h | 803 to 1139 | 338 to 2 | 337/338 (99 %) | 0 diff (100 %id) | |||
AI248428 | liver and spleen | .h | 700 to 1138 | 441 to 3 | 439/441 (99 %) | 0 diff (100 %id) | |||
AI202837 | anaplastic oligodendroglioma, brain | .f-u | 775 to 1169 | 394 to 1 | 394/396 (99 %) | 1 diff (99.8 %id) | |||
AI290837 | carcinoid, lung | .h | 804 to 1138 | 356 to 22 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 335/335 (100 %) | 17 diff (95.0 %id) | |
AI214655 | carcinoid, lung | .h | 864 to 1139 | 302 to 27 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 276/276 (100 %) | 8 diff (97.2 %id) | |
AI278040 | placenta | .h | 662 to 1138 | 481 to 5 | 477/481 (99 %) | 0 diff (100 %id) | |||
AI266150 | lung | .h | 947 to 1138 | 204 to 13 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 192/194 (98 %) | 8 diff (95.9 %id) | |
AI282226 | lung | .h | 883 to 1138 | 274 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 256/256 (100 %) | 3 diff (98.9 %id) | |
AI205257 | brain, meningioma | .h | 748 to 1124 | 377 to 1 | 377/377 (100 %) | 1 diff (99.8 %id) | |||
AI285805 | esophagus, squamous cell carcinoma | .h | 952 to 1144 | 194 to 2 | tiling clone, | 193/194 (99 %) | 0 diff (100 %id) | ||
AI363497 | anaplastic oligodendroglioma, brain | .h | 723 to 1139 | 424 to 8 | 417/424 (98 %) | 0 diff (100 %id) | |||
AI336667 | invasive adenocarcinoma, lung | .h | 787 to 1135 | 1 to 349 | AAA | Submitted on the opposite strand | 349/349 (100 %) | 6 diff (98.3 %id) | |
AI374715 | .h | 800 to 1138 | 353 to 15 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 339/339 (100 %) | 2 diff (99.5 %id) | ||
AI471897 | lymph node, lymphoma, follicular mixed small and largecell | .h | 884 to 1139 | 271 to 14 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 258/258 (100 %) | 2 diff (99.3 %id) | |
AI885215 | anaplastic oligodendroglioma, brain | .f-u | 680 to 1169 | 490 to 1 | 490/490 (100 %) | 6 diff (98.8 %id) | |||
AI886494 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .f-u | 962 to 1177 | 216 to 1 | 216/216 (100 %) | 8 diff (96.3 %id) | |||
AI929802 | brain, frontal lobe | .h | 676 to 1140 | 472 to 8 | 465/472 (98 %) | 0 diff (100 %id) | |||
AW194562 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .h | 730 to 1138 | 411 to 2 | 410/411 (99 %) | 0 diff (100 %id) | |||
AW117784 | esophagus, squamous cell carcinoma | .f-u | 976 to 1168 | 193 to 1 | 193/194 (99 %) | 1 diff (99.5 %id) | |||
AW130802 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .h | 646 to 1138 | 493 to 1 | 493/493 (100 %) | 1 diff (99.8 %id) | |||
AW263109 | pooled | .h | 729 to 1139 | 412 to 2 | 411/412 (99 %) | 0 diff (100 %id) | |||
AW134510 | .f-u | 678 to 1169 | 509 to 18 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 492/492 (100 %) | 1 diff (99.8 %id) | ||
AW205727 | .h | 668 to 1140 | 490 to 18 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 473/473 (100 %) | 2 diff (99.6 %id) | ||
BE208573 | lung, small cell carcinoma | .c | 698 to 1029 | 11 to 341 | tiling clone, | 331/341 (97 %) | 8 diff (97.7 %id) | ||
AW418598 | carcinoid, lung | .f-u | 737 to 1173 | 437 to 1 | 437/437 (100 %) | 2 diff (99.6 %id) | |||
BC005854 | Colon, adenocarcinoma | .a | 242 to 2520 | 1 to 2279 | available from MGC, AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 2279/2279 (100 %) | 4 diff (99.9 %id) | |
BE293111 | adenocarcinoma cell line, colon | .a | 242 to 883 | 39 to 680 | available from MGC, | 642/680 (94 %) | 9 diff (98.7 %id) | ||
AW769675 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .h | 975 to 1138 | 201 to 38 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 164/164 (100 %) | 1 diff (99.4 %id) | |
BE503766 | carcinoid, lung | .f-u | 684 to 1173 | 490 to 1 | 490/490 (100 %) | 1 diff (99.8 %id) | |||
BE671496 | carcinoid, lung | .f-u | 661 to 1177 | 517 to 1 | 517/517 (100 %) | 0 diff (100 %id) | |||
BE644835 | pooled | .h | 698 to 1139 | 449 to 8 | 442/449 (98 %) | 0 diff (100 %id) | |||
BE675269 | B-cell, chronic lymphotic leukemia | .f-u | 773 to 1342 | 572 to 1 | 572/572 (100 %) | 7 diff (98.8 %id) | |||
BF197618 | Kidney | .f-u | 1011 to 1299 | 295 to 6 | 290/295 (98 %) | 0 diff (100 %id) | |||
BE871874 | adenocarcinoma, colon | .a | 87 to 639 | 1 to 554 | 554/559 (99 %) | 16 diff (97.2 %id) | |||
BE897715 | melanotic melanoma, skin | .a | 234 to 801 | 1 to 571 | 571/572 (99 %) | 7 diff (98.8 %id) | |||
BF131745 | hypernephroma, Kidney | .h | 53 to 461 | 70 to 500 | 431/501 (86 %) | 22 diff (95.7 %id) | |||
BF942052 | medullary carcinoma, thyroid | .h | 748 to 1121 | 47 to 420 | Submitted on the opposite strand | 374/420 (89 %) | 10 diff (97.7 %id) | ||
BF966847 | brain, hippocampus | .a | 1827 to 2470 | 658 to 1 | 658/659 (99 %) | 34 diff (94.9 %id) | |||
BG036737 | brain, hippocampus | .a | 49 to 775 | 1 to 734 | 734/774 (94 %) | 35 diff (95.5 %id) | |||
BG116509 | duodenal adenocarcinoma, cell line, small intestine | .a | 867 to 1556 | 1 to 694 | 694/863 (80 %) | 18 diff (98.0 %id) | |||
BG179033 | adenocarcinoma, cell line, Prostate | .a | 417 to 1133 | 1 to 717 | 717/900 (79 %) | 19 diff (97.9 %id) | |||
BG119391 | adenocarcinoma, cell line, Liver | .a | 1233 to 1895 | 1 to 662 | 662/1086 (60 %) | 10 diff (99.1 %id) | |||
BG491150 | large cell carcinoma, lung | .b | 205 to 1081 | 1 to 882 | R152K L153A E154G L155A L156A ... | tiling clone, | 880/917 (95 %) | 24 diff (97.4 %id) | |
BG470341 | adenocarcinoma cell line, colon | .a | 241 to 754 | 1 to 526 | 526/661 (79 %) | 21 diff (96.9 %id) | |||
BG546010 | lung | .h | 463 to 1138 | 1 to 677 | 677/697 (97 %) | 4 diff (99.5 %id) | |||
BG576786 | breast, mammary adenocarcinoma, cell line | .e | 552 to 1464 | 1 to 920 | F141X | tiling clone, | 920/934 (98 %) | 23 diff (97.6 %id) | |
BG743029 | skin | .a | 1182 to 1923 | 1 to 741 | 741/741 (100 %) | 3 diff (99.6 %id) | |||
BG707900 | brain, hypothalamus | .a | 49 to 764 | 1 to 713 | 713/713 (100 %) | 11 diff (98.5 %id) | |||
BG706699 | brain, hypothalamus | .a | 49 to 828 | 1 to 775 | 775/775 (100 %) | 15 diff (98.1 %id) | |||
BG769909 | melanotic melanoma, high MDR (cell line), skin | .a | 33 to 912 | 1 to 880 | 880/883 (99 %) | 32 diff (96.4 %id) | |||
BI822661 | pooled brain, lung, testis | .a | 97 to 878 | 1 to 783 | 783/783 (100 %) | 1 diff (99.9 %id) | |||
BI761443 | pooled colon, kidney, stomach | .h | 146 to 827 | 1 to 678 | 678/678 (100 %) | 4 diff (99.5 %id) | |||
BI756865 | brain | .a | 42 to 851 | 1 to 813 | 813/818 (99 %) | 24 diff (97.1 %id) | |||
BI911715 | leukocyte | .a | 216 to 847 | 174 to 814 | 641/817 (78 %) | 26 diff (96.9 %id) | |||
BI521100 | pooled pancreas and spleen | .a | 63 to 740 | 1 to 696 | 696/822 (84 %) | 35 diff (95.8 %id) | |||
BI553021 | brain, hippocampus | .a | 49 to 912 | 1 to 863 | 863/882 (97 %) | 32 diff (96.4 %id) | |||
BI458554 | brain, hypothalamus | .a | 49 to 855 | 1 to 802 | 802/844 (95 %) | 19 diff (97.8 %id) | |||
BI862143 | breast, mammary adenocarcinoma, cell line | .f-u | 621 to 1301 | 1 to 680 | 680/680 (100 %) | 1 diff (99.9 %id) | |||
BM009795 | amelanotic melanoma, cell line, skin | .h | 354 to 1047 | 1 to 694 | 694/694 (100 %) | 2 diff (99.8 %id) | |||
BM011583 | brain, neuroblastoma, cell line | .h | 118 to 811 | 1 to 692 | 692/694 (99 %) | 6 diff (99.2 %id) | |||
BM916831 | amelanotic melanoma, cell line, skin | .h | 357 to 1129 | 1 to 778 | 778/1112 (69 %) | 30 diff (97.4 %id) | |||
BM561668 | blood, natural killer cells, cell line | .a | 657 to 1459 | 1 to 808 | 808/964 (83 %) | 17 diff (98.3 %id) | |||
BM918199 | blood, natural killer cells, cell line | .a | 174 to 705 | 1 to 532 | 532/1146 (46 %) | 18 diff (98.5 %id) | |||
BM474126 | leiomyosarcoma, uterus | .h | 723 to 1138 | 1 to 416 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 416/416 (100 %) | 2 diff (99.6 %id) | |
BM454672 | embryonal carcinoma, cell line, testis | .a | 964 to 1810 | 1 to 858 | 858/1050 (81 %) | 28 diff (97.4 %id) | |||
BI966197 | Islets of Langerhans, Pancreas | .h | 594 to 1089 | 1 to 496 | 496/496 (100 %) | 1 diff (99.8 %id) | |||
CK904061 | Islets of Langerhans, Pancreas | .h | 578 to 1140 | 1 to 563 | 563/570 (98 %) | 1 diff (99.9 %id) | |||
BM920365 | pooled lung and spleen | .i | 1 to 757 | 1 to 765 | V61G L70M C76G C80R E83Q ... | tiling clone, | 765/1189 (64 %) | 25 diff (97.9 %id) | |
BM923031 | leukocyte | .f-u | 303 to 1177 | 12 to 887 | tiling clone, | 876/953 (91 %) | 6 diff (99.4 %id) | ||
BQ059574 | lymph, lymphoma, cell line | .a | 325 to 1185 | 1 to 867 | 867/988 (87 %) | 13 diff (98.7 %id) | |||
BM988231 | mixed | .h | 895 to 1138 | 262 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 244/244 (100 %) | 1 diff (99.6 %id) | |
BQ064844 | lymph, lymphoma, cell line | .a | 325 to 1185 | 1 to 867 | 867/1019 (85 %) | 12 diff (98.9 %id) | |||
BQ065969 | lymph, lymphoma, cell line | .a | 325 to 1222 | 1 to 905 | 903/1045 (86 %) | 16 diff (98.5 %id) | |||
BQ066444 | lymph, lymphoma, cell line | .a | 348 to 1015 | 46 to 716 | 671/1075 (62 %) | 6 diff (99.5 %id) | |||
BQ225040 | epithelioid carcinoma, Pancreas | .a | 231 to 709 | 1 to 481 | 481/1059 (45 %) | 7 diff (99.4 %id) | |||
BQ437032 | embryonal carcinoma, cell line, testis | .c | 918 to 1759 | 1 to 857 | tiling clone, | 857/859 (99 %) | 21 diff (97.6 %id) | ||
BU182670 | melanotic melanoma, skin | .a | 74 to 655 | 5 to 598 | 593/1031 (57 %) | 29 diff (97.2 %id) | |||
BQ918294 | large cell carcinoma, lung | .a | 305 to 1183 | 1 to 882 | 880/971 (90 %) | 24 diff (97.6 %id) | |||
BQ945496 | epidermoid carcinoma, cell line, lung | .h | 330 to 747 | 1 to 423 | 423/1347 (31 %) | 12 diff (99.2 %id) | |||
BU932900 | mixed (pool of 40 RNAs) | .h | 337 to 743 | 1 to 415 | 415/866 (47 %) | 14 diff (98.4 %id) | |||
CX788516 | human embryonic stem cells | .a | 61 to 841 | 1 to 781 | 781/781 (100 %) | 0 diff (100 %id) | |||
CD513517 | brain, Pituitary | .a | 941 to 1769 | 1 to 836 | 836/875 (95 %) | 13 diff (98.6 %id) | |||
CF995586 | Pooled Chondrosarcoma Tumor cells | .a | 291 to 881 | 19 to 612 | 594/959 (61 %) | 35 diff (96.4 %id) | |||
CF130679 | Chondrosarcoma Lung Metastasis cell lines, lung | .h | 640 to 1139 | 1 to 501 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 501/501 (100 %) | 1 diff (99.9 %id) | |
CF130211 | Chondrosarcoma Lung Metastasis cell lines, lung | .h | 502 to 1143 | 1 to 640 | tiling clone, AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 640/640 (100 %) | 2 diff (99.7 %id) | |
TI_57220114 | .a | 43 to 851 | 29 to 840 | 812/845 (96 %) | 25 diff (97.1 %id) | ||||
TI_57198759 | .a | 88 to 878 | 64 to 854 | 791/854 (92 %) | 7 diff (99.2 %id) | ||||
TI_57147353 | .h | 146 to 827 | 35 to 712 | 678/712 (95 %) | 6 diff (99.2 %id) | ||||
TI_57234186 | .a | 216 to 847 | 174 to 814 | 641/817 (78 %) | 26 diff (96.9 %id) | ||||
TI_44170511 | .a | 54 to 912 | 84 to 941 | 858/960 (89 %) | 33 diff (96.6 %id) | ||||
TI_57193487 | .f-u | 620 to 1301 | 47 to 727 | 681/681 (100 %) | 1 diff (99.9 %id) | ||||
TI_59384567 | .h | 355 to 1047 | 58 to 750 | 693/693 (100 %) | 1 diff (99.9 %id) | ||||
TI_59380752 | .h | 119 to 811 | 116 to 806 | 691/693 (99 %) | 5 diff (99.3 %id) | ||||
N56091 | .h | 1 to 265 | 1 to 266 | 266/266 (100 %) | 3 diff (98.9 %id) | ||||
BP275100 | Kidney | .a | 54 to 637 | 1 to 584 | 584/584 (100 %) | 0 diff (100 %id) | |||
DA626793 | Kidney | .a | 55 to 558 | 2 to 505 | capped | 504/504 (100 %) | 0 diff (100 %id) | ||
DA628475 | Kidney | .a | 55 to 589 | 2 to 543 | capped | 542/542 (100 %) | 6 diff (98.9 %id) | ||
DA634702 | Kidney | .a | 50 to 626 | 2 to 578 | capped | 577/577 (100 %) | 6 diff (99.0 %id) | ||
CB130879 | Liver | .a | 746 to 1230 | 1 to 485 | 485/485 (100 %) | 1 diff (99.8 %id) | |||
CB140338 | Liver | .a | 54 to 416 | 1 to 363 | 363/363 (100 %) | 0 diff (100 %id) | |||
DA650630 | .a | 55 to 558 | 2 to 505 | capped | 504/504 (100 %) | 0 diff (100 %id) | |||
DA668006 | esophagus | .a | 55 to 515 | 2 to 462 | capped | 461/461 (100 %) | 0 diff (100 %id) | ||
NM_018346.1 | .a | 23 to 2521 | 1 to 2499 | exact | RefSeq, | 2499/2499 (100 %) | 1 diff (100.0 %id) | ||
DA695296 | .a | 48 to 622 | 2 to 576 | capped | 575/575 (100 %) | 2 diff (99.7 %id) | |||
DA708697 | .a | 54 to 606 | 2 to 555 | capped | 554/554 (100 %) | 3 diff (99.5 %id) | |||
DC370283 | .a | 14 to 268 | 1 to 255 | 255/255 (100 %) | 0 diff (100 %id) | ||||
DC370821 | .e | 1 to 513 | 1 to 513 | tiling clone, | 513/513 (100 %) | 7 diff (98.7 %id) | |||
DA781022 | brain | .a | 15 to 582 | 2 to 570 | capped | 569/569 (100 %) | 1 diff (99.9 %id) | ||
DA816385 | .a | 55 to 548 | 2 to 495 | capped | 494/494 (100 %) | 2 diff (99.6 %id) | |||
DA827084 | pericardium | .a | 55 to 613 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
AU137779 | placenta | .a | 24 to 569 | 2 to 547 | capped | 546/546 (100 %) | 1 diff (99.9 %id) | ||
AU157311 | placenta | .a | 2063 to 2521 | 459 to 1 | 459/459 (100 %) | 35 diff (92.4 %id) | |||
DA839889 | placenta | .a | 55 to 598 | 2 to 546 | capped | 545/547 (99 %) | 3 diff (99.5 %id) | ||
DA868874 | Prostate | .a | 50 to 450 | 2 to 402 | capped | 401/401 (100 %) | 6 diff (98.6 %id) | ||
DA875431 | Prostate | .a | 242 to 813 | 2 to 573 | capped | 572/572 (100 %) | 3 diff (99.5 %id) | ||
DA879245 | Prostate | .a | 23 to 587 | 2 to 571 | capped | 570/570 (100 %) | 5 diff (99.2 %id) | ||
DA880157 | Prostate | .a | 55 to 292 | 2 to 245 | capped | 244/244 (100 %) | 3 diff (98.8 %id) | ||
DA889971 | .a | 55 to 548 | 2 to 495 | capped | 494/494 (100 %) | 4 diff (99.2 %id) | |||
DC385329 | rectum | .e | 12 to 498 | 1 to 487 | tiling clone, | 487/487 (100 %) | 1 diff (99.8 %id) | ||
CR984042 | T-Lymphocytes | .k-u | 1 to 632 | 1 to 633 | exact | tiling clone, | 633/633 (100 %) | 1 diff (99.9 %id) | |
CT005166 | T-Lymphocytes | .a | 63 to 543 | 1 to 481 | 481/481 (100 %) | 2 diff (99.6 %id) | |||
BM835873 | stomach | .a | 54 to 206 | 1 to 153 | 153/153 (100 %) | 4 diff (97.4 %id) | |||
BM831113 | stomach | .h | 427 to 1129 | 1 to 702 | 702/702 (100 %) | 7 diff (99.1 %id) | |||
BQ082284 | Ascites, stomach | .i | 123 to 538 | 1 to 416 | 416/416 (100 %) | 1 diff (99.8 %id) | |||
F26206 | pectoral muscle (after mastectomy) | .h | 743 to 1133 | 11 to 400 | 390/400 (97 %) | 6 diff (98.5 %id) | |||
DA912134 | .a | 55 to 623 | 2 to 570 | capped | 569/569 (100 %) | 2 diff (99.7 %id) | |||
DA912179 | .a | 969 to 1532 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | |||
DA913551 | .a | 29 to 522 | 2 to 495 | capped | 494/494 (100 %) | 5 diff (99.0 %id) | |||
DA920960 | small intestine | .a | 80 to 633 | 2 to 555 | capped | 554/554 (100 %) | 3 diff (99.5 %id) | ||
DA923646 | small intestine | .a | 55 to 635 | 2 to 582 | capped | 581/581 (100 %) | 0 diff (100 %id) | ||
DA924323 | small intestine | .a | 55 to 635 | 2 to 582 | capped | 581/581 (100 %) | 2 diff (99.7 %id) | ||
DA932184 | Spleen | .a | 55 to 616 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
DA936440 | Spleen | .a | 55 to 642 | 2 to 589 | capped | 588/588 (100 %) | 1 diff (99.9 %id) | ||
DA940180 | Spleen | .f-u | 1 to 507 | 2 to 509 | tiling clone, capped | 508/508 (100 %) | 1 diff (99.9 %id) | ||
BP342237 | stomach mucosa | .a | 54 to 631 | 1 to 578 | 578/578 (100 %) | 1 diff (99.9 %id) | |||
DA969206 | stomach | .a | 55 to 336 | 2 to 283 | capped | 282/282 (100 %) | 0 diff (100 %id) | ||
T30665 | eye | .h | 461 to 1045 | 1 to 604 | 604/604 (100 %) | 18 diff (97.1 %id) | |||
T33446 | brain | .h | 798 to 1140 | 343 to 1 | 343/343 (100 %) | 1 diff (99.8 %id) | |||
DN998069 | breast cancer, Mammary gland (cancer tissue) | .a | 57 to 505 | 1 to 449 | 449/449 (100 %) | 6 diff (98.7 %id) | |||
BM193285 | leukopheresis | .b | 1 to 362 | 1 to 362 | tiling clone, | 362/364 (99 %) | 16 diff (95.7 %id) | ||
BM153531 | leukopheresis | .h | 735 to 1136 | 419 to 17 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 403/404 (99 %) | 33 diff (91.9 %id) | |
DC393589 | colon, tumor tissue | .a | 16 to 552 | 1 to 537 | 537/543 (98 %) | 4 diff (99.3 %id) | |||
BP356858 | mammary gland | .a | 229 to 806 | 1 to 579 | 579/583 (99 %) | 16 diff (97.3 %id) | |||
DB048982 | testis | .a | 55 to 411 | 2 to 358 | capped | 357/363 (98 %) | 2 diff (99.5 %id) | ||
DB114381 | thymus | .a | 55 to 552 | 2 to 499 | capped | 498/504 (98 %) | 4 diff (99.3 %id) | ||
DB118338 | thymus | .a | 55 to 548 | 2 to 495 | capped | 494/494 (100 %) | 2 diff (99.6 %id) | ||
DB133342 | thymus | .j | 189 to 741 | 2 to 554 | exact | tiling clone, capped | 553/553 (100 %) | 2 diff (99.7 %id) | |
TI_149300076 | .h | 289 to 1138 | 924 to 78 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 847/942 (89 %) | 13 diff (98.7 %id) | ||
TI_149308691 | .h | 326 to 1138 | 923 to 124 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 800/902 (88 %) | 28 diff (96.9 %id) | ||
TI_153989780 | .h | 509 to 1140 | 729 to 102 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 628/643 (97 %) | 23 diff (96.5 %id) | ||
TI_154041874 | .h | 504 to 1139 | 720 to 83 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 638/988 (64 %) | 5 diff (99.5 %id) | ||
TI_154192245 | .h | 502 to 1143 | 51 to 690 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 640/640 (100 %) | 2 diff (99.7 %id) | ||
TI_154192691 | .h | 640 to 1139 | 53 to 553 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 501/501 (100 %) | 1 diff (99.9 %id) | ||
DB197038 | trachea | .a | 181 to 740 | 19 to 578 | capped | 560/560 (100 %) | 8 diff (98.6 %id) | ||
DB197912 | trachea | .a | 55 to 633 | 2 to 580 | capped | 579/579 (100 %) | 2 diff (99.7 %id) | ||
DC415055 | trachea | .e | 12 to 538 | 1 to 527 | tiling clone, | 527/527 (100 %) | 2 diff (99.7 %id) | ||
BQ012945 | placenta | .h | 710 to 1139 | 448 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 430/430 (100 %) | 0 diff (100 %id) | |
BM979861 | lung, Primary Lung Epithelial Cells | .h | 538 to 1138 | 619 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 601/601 (100 %) | 11 diff (98.2 %id) | |
BM976148 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .h | 392 to 1138 | 764 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 746/746 (100 %) | 5 diff (99.4 %id) | |
BM713111 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 501 to 875 | 1 to 375 | 375/375 (100 %) | 0 diff (100 %id) | |||
BM717036 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 500 to 1138 | 1 to 641 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 641/641 (100 %) | 2 diff (99.7 %id) | |
BM715881 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 546 to 1140 | 1 to 595 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 595/595 (100 %) | 1 diff (99.9 %id) | |
BM701378 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1196 to 1424 | 1 to 229 | 229/229 (100 %) | 0 diff (100 %id) | |||
BM717154 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1196 to 1838 | 1 to 642 | 642/642 (100 %) | 3 diff (99.6 %id) | |||
BU738633 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 507 to 1140 | 653 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 635/635 (100 %) | 1 diff (99.9 %id) | |
BM678115 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 615 to 1139 | 544 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 526/526 (100 %) | 1 diff (99.9 %id) | |
BM725635 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 203 to 645 | 1 to 440 | fully sequenced, | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 440/440 (100 %) | 4 diff (99.1 %id) | |
BM677032 | eye, fetal eye | .f-u | 592 to 1187 | 596 to 1 | fully sequenced, | 596/596 (100 %) | 3 diff (99.5 %id) | ||
BM721295 | eye, fetal eye | .f-u | 32 to 622 | 1 to 591 | tiling clone, fully sequenced, | 591/591 (100 %) | 2 diff (99.7 %id) | ||
BU741917 | eye, fetal eye | .h | 390 to 1140 | 770 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 752/752 (100 %) | 1 diff (99.9 %id) | |
CN480170 | Knee, Osteoarthritic Cartilage | .h | 504 to 1139 | 656 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 638/639 (99 %) | 5 diff (99.3 %id) | |
BQ447550 | Knee, Osteoarthritic Cartilage | .h | 484 to 1138 | 672 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 654/654 (100 %) | 7 diff (99.0 %id) | |
CA413442 | Chondrosarcoma Grade II, Left Pelvis | .h | 489 to 1139 | 670 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 652/652 (100 %) | 2 diff (99.7 %id) | |
BQ575194 | Chondrosarcoma Grade II, Left Pelvis | .h | 497 to 1138 | 661 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 643/643 (100 %) | 7 diff (99.0 %id) | |
BQ772020 | Chondrosarcoma Grade II, Left Pelvis | .h | 380 to 1140 | 779 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 761/761 (100 %) | 3 diff (99.7 %id) | |
BQ773775 | Chondrosarcoma Grade II, Left Pelvis | .h | 492 to 1138 | 665 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 647/647 (100 %) | 3 diff (99.6 %id) | |
CA425932 | cell lines, Chondrosarcoma | .h | 368 to 1138 | 785 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 767/768 (99 %) | 5 diff (99.4 %id) | |
CA748700 | Alveolar Macrophage, lung | .h | 484 to 1138 | 674 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 656/656 (100 %) | 1 diff (99.9 %id) | |
TI_151776947 | .h | 544 to 1140 | 76 to 667 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 592/667 (88 %) | 6 diff (99.2 %id) | ||
TI_151786176 | .a | 653 to 1349 | 104 to 801 | 698/801 (87 %) | 6 diff (99.3 %id) | ||||
DB265176 | uterus | .a | 55 to 647 | 2 to 594 | capped | 593/593 (100 %) | 2 diff (99.7 %id) | ||
DB269365 | uterus | .a | 55 to 499 | 2 to 447 | capped | 446/446 (100 %) | 2 diff (99.6 %id) | ||
DB270648 | uterus | .a | 53 to 552 | 2 to 501 | capped | 500/506 (98 %) | 4 diff (99.3 %id) | ||
AA345876 | gall bladder | .h | 640 to 1139 | 1 to 501 | Suspected internal deletion, this clone was ignored | 501/501 (100 %) | 1 diff (99.9 %id) | ||
DA077812 | cerebellum | .h | 640 to 1139 | 1 to 501 | capped | Suspected internal deletion, this clone was ignored | 501/501 (100 %) | 1 diff (99.9 %id) | |
DA121117 | cerebellum | .h | 502 to 1143 | 1 to 640 | tiling clone, capped | This clone was ignored | 640/640 (100 %) | 2 diff (99.7 %id) | |
DB300500 | cerebellum | .h | 502 to 1143 | 1 to 640 | tiling clone, | This clone was ignored | 640/640 (100 %) | 2 diff (99.7 %id) | |
DA381244 | thalamus | .a | 43 to 851 | 29 to 840 | capped | Suspected internal deletion, this clone was ignored | 812/845 (96 %) | 25 diff (97.1 %id) | |
CD629219 | .a | 88 to 878 | 64 to 854 | Suspected internal deletion, this clone was ignored | 791/854 (92 %) | 7 diff (99.2 %id) | |||
BJ995736 | hepatoblastoma | .h | 146 to 827 | 35 to 712 | Suspected internal deletion, this clone was ignored | 678/712 (95 %) | 6 diff (99.2 %id) | ||
BJ995737 | hepatoblastoma | .a | 216 to 847 | 174 to 814 | Suspected internal deletion, this clone was ignored | 641/817 (78 %) | 26 diff (96.9 %id) | ||
BE279780 | choriocarcinoma, placenta | .a | 54 to 912 | 84 to 941 | This clone was ignored | 858/960 (89 %) | 33 diff (96.6 %id) | ||
BG479682 | choriocarcinoma, placenta | .f-u | 620 to 1301 | 47 to 727 | This clone was ignored | 681/681 (100 %) | 1 diff (99.9 %id) | ||
BG482092 | choriocarcinoma, placenta | .h | 355 to 1047 | 58 to 750 | This clone was ignored | 693/693 (100 %) | 1 diff (99.9 %id) | ||
DA679577 | .h | 119 to 811 | 116 to 806 | capped | Suspected internal deletion, this clone was ignored | 691/693 (99 %) | 5 diff (99.3 %id) | ||
DB030319 | testis | .h | 1 to 265 | 1 to 266 | capped | This clone was ignored | 266/266 (100 %) | 3 diff (98.9 %id) | |
DB336975 | testis | .a | 54 to 637 | 1 to 584 | This clone was ignored | 584/584 (100 %) | 0 diff (100 %id) | ||
DA626793 | Kidney | .a | 55 to 558 | 2 to 505 | capped | 504/504 (100 %) | 0 diff (100 %id) | ||
DA628475 | Kidney | .a | 55 to 589 | 2 to 543 | capped | 542/542 (100 %) | 6 diff (98.9 %id) | ||
DA634702 | Kidney | .a | 50 to 626 | 2 to 578 | capped | 577/577 (100 %) | 6 diff (99.0 %id) | ||
CB130879 | Liver | .a | 746 to 1230 | 1 to 485 | 485/485 (100 %) | 1 diff (99.8 %id) | |||
CB140338 | Liver | .a | 54 to 416 | 1 to 363 | 363/363 (100 %) | 0 diff (100 %id) | |||
DA650630 | .a | 55 to 558 | 2 to 505 | capped | 504/504 (100 %) | 0 diff (100 %id) | |||
DA668006 | esophagus | .a | 55 to 515 | 2 to 462 | capped | 461/461 (100 %) | 0 diff (100 %id) | ||
NM_018346.1 | .a | 23 to 2521 | 1 to 2499 | exact | RefSeq, | 2499/2499 (100 %) | 1 diff (100.0 %id) | ||
DA695296 | .a | 48 to 622 | 2 to 576 | capped | 575/575 (100 %) | 2 diff (99.7 %id) | |||
DA708697 | .a | 54 to 606 | 2 to 555 | capped | 554/554 (100 %) | 3 diff (99.5 %id) | |||
DC370283 | .a | 14 to 268 | 1 to 255 | 255/255 (100 %) | 0 diff (100 %id) | ||||
DC370821 | .e | 1 to 513 | 1 to 513 | tiling clone, | 513/513 (100 %) | 7 diff (98.7 %id) | |||
DA781022 | brain | .a | 15 to 582 | 2 to 570 | capped | 569/569 (100 %) | 1 diff (99.9 %id) | ||
DA816385 | .a | 55 to 548 | 2 to 495 | capped | 494/494 (100 %) | 2 diff (99.6 %id) | |||
DA827084 | pericardium | .a | 55 to 613 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
AU137779 | placenta | .a | 24 to 569 | 2 to 547 | capped | 546/546 (100 %) | 1 diff (99.9 %id) | ||
AU157311 | placenta | .a | 2063 to 2521 | 459 to 1 | 459/459 (100 %) | 35 diff (92.4 %id) | |||
DA839889 | placenta | .a | 55 to 598 | 2 to 546 | capped | 545/547 (99 %) | 3 diff (99.5 %id) | ||
DA868874 | Prostate | .a | 50 to 450 | 2 to 402 | capped | 401/401 (100 %) | 6 diff (98.6 %id) | ||
DA875431 | Prostate | .a | 242 to 813 | 2 to 573 | capped | 572/572 (100 %) | 3 diff (99.5 %id) | ||
DA879245 | Prostate | .a | 23 to 587 | 2 to 571 | capped | 570/570 (100 %) | 5 diff (99.2 %id) | ||
DA880157 | Prostate | .a | 55 to 292 | 2 to 245 | capped | 244/244 (100 %) | 3 diff (98.8 %id) | ||
DA889971 | .a | 55 to 548 | 2 to 495 | capped | 494/494 (100 %) | 4 diff (99.2 %id) | |||
DC385329 | rectum | .e | 12 to 498 | 1 to 487 | tiling clone, | 487/487 (100 %) | 1 diff (99.8 %id) | ||
CR984042 | T-Lymphocytes | .k-u | 1 to 632 | 1 to 633 | exact | tiling clone, | 633/633 (100 %) | 1 diff (99.9 %id) | |
CT005166 | T-Lymphocytes | .a | 63 to 543 | 1 to 481 | 481/481 (100 %) | 2 diff (99.6 %id) | |||
BM835873 | stomach | .a | 54 to 206 | 1 to 153 | 153/153 (100 %) | 4 diff (97.4 %id) | |||
BM831113 | stomach | .h | 427 to 1129 | 1 to 702 | 702/702 (100 %) | 7 diff (99.1 %id) | |||
BQ082284 | Ascites, stomach | .i | 123 to 538 | 1 to 416 | 416/416 (100 %) | 1 diff (99.8 %id) | |||
BQ082284 | Ascites, stomach | .i | 123 to 538 | 1 to 416 | 416/416 (100 %) | 1 diff (99.8 %id) | |||
F26206 | pectoral muscle (after mastectomy) | .h | 743 to 1133 | 11 to 400 | 390/400 (97 %) | 6 diff (98.5 %id) | |||
DA912134 | .a | 55 to 623 | 2 to 570 | capped | 569/569 (100 %) | 2 diff (99.7 %id) | |||
DA912179 | .a | 969 to 1532 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | |||
DA913551 | .a | 29 to 522 | 2 to 495 | capped | 494/494 (100 %) | 5 diff (99.0 %id) | |||
DA920960 | small intestine | .a | 80 to 633 | 2 to 555 | capped | 554/554 (100 %) | 3 diff (99.5 %id) | ||
DA923646 | small intestine | .a | 55 to 635 | 2 to 582 | capped | 581/581 (100 %) | 0 diff (100 %id) | ||
DA924323 | small intestine | .a | 55 to 635 | 2 to 582 | capped | 581/581 (100 %) | 2 diff (99.7 %id) | ||
DA932184 | Spleen | .a | 55 to 616 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
DA936440 | Spleen | .a | 55 to 642 | 2 to 589 | capped | 588/588 (100 %) | 1 diff (99.9 %id) | ||
DA940180 | Spleen | .f-u | 1 to 507 | 2 to 509 | tiling clone, capped | 508/508 (100 %) | 1 diff (99.9 %id) | ||
BP342237 | stomach mucosa | .a | 54 to 631 | 1 to 578 | 578/578 (100 %) | 1 diff (99.9 %id) | |||
DA969206 | stomach | .a | 55 to 336 | 2 to 283 | capped | 282/282 (100 %) | 0 diff (100 %id) | ||
T30665 | eye | .h | 461 to 1045 | 1 to 604 | 604/604 (100 %) | 18 diff (97.1 %id) | |||
T33446 | brain | .h | 798 to 1140 | 343 to 1 | 343/343 (100 %) | 1 diff (99.8 %id) | |||
DN998069 | breast cancer, Mammary gland (cancer tissue) | .a | 57 to 505 | 1 to 449 | 449/449 (100 %) | 6 diff (98.7 %id) | |||
DN998069 | breast cancer, Mammary gland (cancer tissue) | .a | 57 to 505 | 1 to 449 | 449/449 (100 %) | 6 diff (98.7 %id) | |||
BM193285 | leukopheresis | .b | 1 to 362 | 1 to 362 | tiling clone, | 362/364 (99 %) | 16 diff (95.7 %id) | ||
BM153531 | leukopheresis | .h | 735 to 1136 | 419 to 17 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 403/404 (99 %) | 33 diff (91.9 %id) | |
DC393589 | colon, tumor tissue | .a | 16 to 552 | 1 to 537 | 537/543 (98 %) | 4 diff (99.3 %id) | |||
BP356858 | mammary gland | .a | 229 to 806 | 1 to 579 | 579/583 (99 %) | 16 diff (97.3 %id) | |||
DB048982 | testis | .a | 55 to 411 | 2 to 358 | capped | 357/363 (98 %) | 2 diff (99.5 %id) | ||
DB114381 | thymus | .a | 55 to 552 | 2 to 499 | capped | 498/504 (98 %) | 4 diff (99.3 %id) | ||
DB118338 | thymus | .a | 55 to 548 | 2 to 495 | capped | 494/494 (100 %) | 2 diff (99.6 %id) | ||
DB133342 | thymus | .j | 189 to 741 | 2 to 554 | exact | tiling clone, capped | 553/553 (100 %) | 2 diff (99.7 %id) | |
TI_149300076 | .h | 289 to 1138 | 924 to 78 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 847/942 (89 %) | 13 diff (98.7 %id) | ||
TI_149308691 | .h | 326 to 1138 | 923 to 124 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 800/902 (88 %) | 28 diff (96.9 %id) | ||
TI_153989780 | .h | 509 to 1140 | 729 to 102 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 628/643 (97 %) | 23 diff (96.5 %id) | ||
TI_154041874 | .h | 504 to 1139 | 720 to 83 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 638/988 (64 %) | 5 diff (99.5 %id) | ||
TI_154192245 | .h | 502 to 1143 | 51 to 690 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 640/640 (100 %) | 2 diff (99.7 %id) | ||
TI_154192691 | .h | 640 to 1139 | 53 to 553 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 501/501 (100 %) | 1 diff (99.9 %id) | ||
DB197038 | trachea | .a | 181 to 740 | 19 to 578 | capped | 560/560 (100 %) | 8 diff (98.6 %id) | ||
DB197912 | trachea | .a | 55 to 633 | 2 to 580 | capped | 579/579 (100 %) | 2 diff (99.7 %id) | ||
DC415055 | trachea | .e | 12 to 538 | 1 to 527 | tiling clone, | 527/527 (100 %) | 2 diff (99.7 %id) | ||
BQ012945 | placenta | .h | 710 to 1139 | 448 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 430/430 (100 %) | 0 diff (100 %id) | |
BM979861 | lung, Primary Lung Epithelial Cells | .h | 538 to 1138 | 619 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 601/601 (100 %) | 11 diff (98.2 %id) | |
BM979861 | lung, Primary Lung Epithelial Cells | .h | 538 to 1138 | 619 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 601/601 (100 %) | 11 diff (98.2 %id) | |
BM976148 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .h | 392 to 1138 | 764 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 746/746 (100 %) | 5 diff (99.4 %id) | |
BM976148 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .h | 392 to 1138 | 764 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 746/746 (100 %) | 5 diff (99.4 %id) | |
BM713111 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 501 to 875 | 1 to 375 | 375/375 (100 %) | 0 diff (100 %id) | |||
BM713111 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 501 to 875 | 1 to 375 | 375/375 (100 %) | 0 diff (100 %id) | |||
BM717036 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 500 to 1138 | 1 to 641 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 641/641 (100 %) | 2 diff (99.7 %id) | |
BM717036 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 500 to 1138 | 1 to 641 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 641/641 (100 %) | 2 diff (99.7 %id) | |
BM715881 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 546 to 1140 | 1 to 595 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 595/595 (100 %) | 1 diff (99.9 %id) | |
BM715881 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 546 to 1140 | 1 to 595 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 595/595 (100 %) | 1 diff (99.9 %id) | |
BM701378 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1196 to 1424 | 1 to 229 | 229/229 (100 %) | 0 diff (100 %id) | |||
BM701378 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1196 to 1424 | 1 to 229 | 229/229 (100 %) | 0 diff (100 %id) | |||
BM717154 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1196 to 1838 | 1 to 642 | 642/642 (100 %) | 3 diff (99.6 %id) | |||
BM717154 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1196 to 1838 | 1 to 642 | 642/642 (100 %) | 3 diff (99.6 %id) | |||
BU738633 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 507 to 1140 | 653 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 635/635 (100 %) | 1 diff (99.9 %id) | |
BU738633 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 507 to 1140 | 653 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 635/635 (100 %) | 1 diff (99.9 %id) | |
BM678115 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 615 to 1139 | 544 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 526/526 (100 %) | 1 diff (99.9 %id) | |
BM678115 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 615 to 1139 | 544 to 19 | fully sequenced, AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 526/526 (100 %) | 1 diff (99.9 %id) | |
BM725635 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 203 to 645 | 1 to 440 | fully sequenced, | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 440/440 (100 %) | 4 diff (99.1 %id) | |
BM725635 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 203 to 645 | 1 to 440 | fully sequenced, | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 440/440 (100 %) | 4 diff (99.1 %id) | |
BM677032 | eye, fetal eye | .f-u | 592 to 1187 | 596 to 1 | fully sequenced, | 596/596 (100 %) | 3 diff (99.5 %id) | ||
BM677032 | eye, fetal eye | .f-u | 592 to 1187 | 596 to 1 | fully sequenced, | 596/596 (100 %) | 3 diff (99.5 %id) | ||
BM721295 | eye, fetal eye | .f-u | 32 to 622 | 1 to 591 | tiling clone, fully sequenced, | 591/591 (100 %) | 2 diff (99.7 %id) | ||
BM721295 | eye, fetal eye | .f-u | 32 to 622 | 1 to 591 | tiling clone, fully sequenced, | 591/591 (100 %) | 2 diff (99.7 %id) | ||
BU741917 | eye, fetal eye | .h | 390 to 1140 | 770 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 752/752 (100 %) | 1 diff (99.9 %id) | |
BU741917 | eye, fetal eye | .h | 390 to 1140 | 770 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 752/752 (100 %) | 1 diff (99.9 %id) | |
CN480170 | Knee, Osteoarthritic Cartilage | .h | 504 to 1139 | 656 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 638/639 (99 %) | 5 diff (99.3 %id) | |
CN480170 | Knee, Osteoarthritic Cartilage | .h | 504 to 1139 | 656 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 638/639 (99 %) | 5 diff (99.3 %id) | |
BQ447550 | Knee, Osteoarthritic Cartilage | .h | 484 to 1138 | 672 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 654/654 (100 %) | 7 diff (99.0 %id) | |
BQ447550 | Knee, Osteoarthritic Cartilage | .h | 484 to 1138 | 672 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 654/654 (100 %) | 7 diff (99.0 %id) | |
CA413442 | Chondrosarcoma Grade II, Left Pelvis | .h | 489 to 1139 | 670 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 652/652 (100 %) | 2 diff (99.7 %id) | |
CA413442 | Chondrosarcoma Grade II, Left Pelvis | .h | 489 to 1139 | 670 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 652/652 (100 %) | 2 diff (99.7 %id) | |
BQ575194 | Chondrosarcoma Grade II, Left Pelvis | .h | 497 to 1138 | 661 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 643/643 (100 %) | 7 diff (99.0 %id) | |
BQ575194 | Chondrosarcoma Grade II, Left Pelvis | .h | 497 to 1138 | 661 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 643/643 (100 %) | 7 diff (99.0 %id) | |
BQ772020 | Chondrosarcoma Grade II, Left Pelvis | .h | 380 to 1140 | 779 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 761/761 (100 %) | 3 diff (99.7 %id) | |
BQ772020 | Chondrosarcoma Grade II, Left Pelvis | .h | 380 to 1140 | 779 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 761/761 (100 %) | 3 diff (99.7 %id) | |
BQ773775 | Chondrosarcoma Grade II, Left Pelvis | .h | 492 to 1138 | 665 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 647/647 (100 %) | 3 diff (99.6 %id) | |
BQ773775 | Chondrosarcoma Grade II, Left Pelvis | .h | 492 to 1138 | 665 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 647/647 (100 %) | 3 diff (99.6 %id) | |
CA425932 | cell lines, Chondrosarcoma | .h | 368 to 1138 | 785 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 767/768 (99 %) | 5 diff (99.4 %id) | |
CA425932 | cell lines, Chondrosarcoma | .h | 368 to 1138 | 785 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 767/768 (99 %) | 5 diff (99.4 %id) | |
CA748700 | Alveolar Macrophage, lung | .h | 484 to 1138 | 674 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 656/656 (100 %) | 1 diff (99.9 %id) | |
CA748700 | Alveolar Macrophage, lung | .h | 484 to 1138 | 674 to 19 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 656/656 (100 %) | 1 diff (99.9 %id) | |
TI_151776947 | .h | 544 to 1140 | 76 to 667 | AAA | Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) | 592/667 (88 %) | 6 diff (99.2 %id) | ||
TI_151786176 | .a | 653 to 1349 | 104 to 801 | 698/801 (87 %) | 6 diff (99.3 %id) | ||||
DB265176 | uterus | .a | 55 to 647 | 2 to 594 | capped | 593/593 (100 %) | 2 diff (99.7 %id) | ||
DB269365 | uterus | .a | 55 to 499 | 2 to 447 | capped | 446/446 (100 %) | 2 diff (99.6 %id) | ||
DB270648 | uterus | .a | 53 to 552 | 2 to 501 | capped | 500/506 (98 %) | 4 diff (99.3 %id) |